General Information of the Compound
| Compound ID |
CP0002027
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-Methyl-3-((S)-1-pyrrolidin-2-ylmethoxy)-pyridine
Show/Hide
|
||||||||||||||||||
| Synonyms |
(R)-2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine
2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine
2-Methyl-3-(2S-pyrrolidinylmethoxy)pyridine
2-methyl-3-[[(2R)-pyrrolidin-2-yl]methoxy]pyridine
2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine
A 94224
ABT 089
ABT-089
Pozanicline
Pozanicline (USAN)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C11H16N2O
|
||||||||||||||||||
| Molecular Weight |
192.262
|
||||||||||||||||||
| Canonical SMILES |
Cc1ncccc1OC[C@@H]1CCCN1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
YRVIKLBSVVNSHF-JTQLQIEISA-N
|
||||||||||||||||||
| CAS |
161417-03-4
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound